{"id":407,"date":"2023-08-25T13:47:56","date_gmt":"2023-08-25T05:47:56","guid":{"rendered":"https:\/\/consulting-hmk.com\/?p=407"},"modified":"2024-01-18T09:54:44","modified_gmt":"2024-01-18T01:54:44","slug":"artificial-lens-approved-for-marketing","status":"publish","type":"post","link":"https:\/\/www.consulting-hmk.com\/fr\/lentilles-artificielles-approuvees-pour-la-commercialisation\/","title":{"rendered":"Lentille artificielle : autorisation de mise sur le march\u00e9"},"content":{"rendered":"<p><span style=\"font-family: arial, helvetica, sans-serif; font-size: 14pt;\">\u00a0 \u00a0 \u00a0 R\u00e9cemment, le produit innovant \"Artificial Lens\" d'Alcon Laboratories, Inc. a \u00e9t\u00e9 approuv\u00e9 par la NMPA chinoise.<\/span><\/p>\n<p><span style=\"font-size: 14pt;\"><img decoding=\"async\" loading=\"lazy\" class=\"wp-image-408 aligncenter\" title=\"Lentille artificielle : autorisation de mise sur le march\u00e9\" src=\"https:\/\/consulting-hmk.com\/wp-content\/uploads\/2023\/08\/vecteezy_asian-caregiver-doctor-examine-older-patient-use-blood_24120561_351-300x200.jpg\" alt=\"Lentille artificielle : autorisation de mise sur le march\u00e9\" width=\"604\" height=\"402\" srcset=\"https:\/\/www.consulting-hmk.com\/wp-content\/uploads\/2023\/08\/vecteezy_asian-caregiver-doctor-examine-older-patient-use-blood_24120561_351-300x200.jpg 300w, https:\/\/www.consulting-hmk.com\/wp-content\/uploads\/2023\/08\/vecteezy_asian-caregiver-doctor-examine-older-patient-use-blood_24120561_351-1024x683.jpg 1024w, https:\/\/www.consulting-hmk.com\/wp-content\/uploads\/2023\/08\/vecteezy_asian-caregiver-doctor-examine-older-patient-use-blood_24120561_351-768x512.jpg 768w, https:\/\/www.consulting-hmk.com\/wp-content\/uploads\/2023\/08\/vecteezy_asian-caregiver-doctor-examine-older-patient-use-blood_24120561_351-1536x1024.jpg 1536w, https:\/\/www.consulting-hmk.com\/wp-content\/uploads\/2023\/08\/vecteezy_asian-caregiver-doctor-examine-older-patient-use-blood_24120561_351-2048x1365.jpg 2048w\" sizes=\"(max-width: 604px) 100vw, 604px\" \/><\/span><\/p>\n<p><span style=\"font-family: arial, helvetica, sans-serif; font-size: 14pt;\">Ce produit est une lentille intraoculaire \u00e0 chambre post\u00e9rieure en une seule pi\u00e8ce, dont le centre de la surface avant adopte une structure brevet\u00e9e de fa\u00e7onnage du front d'onde. Ce produit convient aux patients adultes atteints d'astigmatisme corn\u00e9en qui ont subi une extraction extracapsulaire de la cataracte afin de retirer le cristallin. Dans un premier temps, le produit est implant\u00e9 pour corriger la vision en \u00e9largissant la profondeur focale, c'est-\u00e0-dire en \u00e9largissant la port\u00e9e visuelle de la vision de loin \u00e0 la vision de pr\u00e8s fonctionnelle tout en conservant une vision de loin consid\u00e9rable, ce qui r\u00e9duit la d\u00e9pendance des patients \u00e0 l'\u00e9gard des lunettes. La commercialisation de ce produit offrira davantage d'options pour le traitement clinique.<\/span><\/p>\n<p><span style=\"font-family: arial, helvetica, sans-serif; font-size: 14pt;\">L'APMN renforcera la surveillance du produit apr\u00e8s sa mise sur le march\u00e9 afin de prot\u00e9ger la s\u00e9curit\u00e9 des dispositifs m\u00e9dicaux utilis\u00e9s par les patients.<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>R\u00e9cemment, le produit innovant \"Artificial Lens\" d'Alcon Laboratories, Inc. a \u00e9t\u00e9 approuv\u00e9 par la NMPA chinoise.<\/p>","protected":false},"author":4,"featured_media":409,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[70],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.consulting-hmk.com\/fr\/wp-json\/wp\/v2\/posts\/407"}],"collection":[{"href":"https:\/\/www.consulting-hmk.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.consulting-hmk.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.consulting-hmk.com\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.consulting-hmk.com\/fr\/wp-json\/wp\/v2\/comments?post=407"}],"version-history":[{"count":0,"href":"https:\/\/www.consulting-hmk.com\/fr\/wp-json\/wp\/v2\/posts\/407\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.consulting-hmk.com\/fr\/wp-json\/wp\/v2\/media\/409"}],"wp:attachment":[{"href":"https:\/\/www.consulting-hmk.com\/fr\/wp-json\/wp\/v2\/media?parent=407"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.consulting-hmk.com\/fr\/wp-json\/wp\/v2\/categories?post=407"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.consulting-hmk.com\/fr\/wp-json\/wp\/v2\/tags?post=407"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}